Hyperkinetic disorders

KRA_PSY_HYPERKIN

attention deficit hyperactivity disorder: A mental disorder characterized by inattention, easy distraction, careless mistakes and avoidance of tasks that require sustained mental focus. These behaviors can lead to maladaptive consequences in the affected individual's life.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F90 Hospital discharge: ICD-9 — 314 Cause of death: ICD-10 — F90 Cause of death: ICD-9 — 314 2 out of 7 registries used, show all original rules.	5052
4. Check minimum number of events None	5052
5. Include endpoints None	5052
6. Filter based on genotype QC (FinnGen only)	5052

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F90-F98
Name in latin: Perturbationes hyperkineticae

NAME	KRA_PSY_HYPERKIN
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F90
HD_ICD_9	314
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F90
COD_ICD_9	314
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hyperkinetic disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5052	3058	1994
Unadjusted period prevalence (%)	0.98	1.04	0.88
Median age at first event (years)	29.18	31.04	26.34

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4191: Matched controls
41610

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N06AX12

ATC

bupropion; oral

9.0

323.0

1214

1809

N05AH04

ATC

quetiapine; oral

5.5

323.0

1753

4822

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

146.4

323.0

761

F90.0

ICD-10 Finland

Disturbance of activity and attention

1151.0

323.0

3914

511

N06BA04

ATC

methylphenidate; oral

154.0

323.0

2644

456

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

66.3

323.0

405

F90.9

ICD-10 Finland

Hyperkinetic disorder, unspecified

110.0

323.0

401

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

7.0

323.0

1744

3858

N06BA12

ATC

lisdexamfetamine; oral

140.5

323.0

499

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.4

309.6

1370

4118

N06AX16

ATC

venlafaxine; oral

4.6

289.0

1201

3357

N06AX11

ATC

mirtazapine; oral

3.6

284.2

1697

6549

N06BA09

ATC

atomoxetine; oral

181.8

262.9

274

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.1

262.1

1236

3845

N06AB10

ATC

escitalopram; oral

3.5

261.5

1609

6263

N05BA04

ATC

oxazepam; oral

3.7

256.9

1404

4952

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

6.1

253.1

767

1481

ZY010

NOMESCO Finland

Hospital outpatient

5.5

249.0

819

1745

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

7.0

237.1

635

1033

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

4.3

224.8

980

2781

N06AB04

ATC

citalopram; systemic

3.8

219.8

1120

3646

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

7.1

218.2

574

905

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

9.2

203.8

450

536

N06AB03

ATC

fluoxetine; oral

4.3

201.5

856

2345

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

6.2

199.0

579

1041

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.5

189.1

765

1988

N06AB06

ATC

sertraline; oral

3.8

188.1

926

2879

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

8.3

182.7

431

570

N03AX09

ATC

lamotrigine; oral

5.2

181.7

616

1325

IGY02

NOMESCO Finland

Psychiatric monitoring contact

6.6

174.4

483

807

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.6

172.1

542

1066

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

5.3

172.0

580

1235

P81

ICPC

Hyperkinetic disorder

20.9

171.5

260

131

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.3

169.6

700

1839

N06AX26

ATC

vortioxetine; oral

4.6

168.4

644

1568

N05AX08

ATC

risperidone; systemic

4.8

164.0

605

1417

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.3

163.5

982

3527

F84.5

ICD-10 Finland

Asperger syndrome

15.5

163.5

277

189

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

5.6

162.8

514

1011

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

8.0

162.3

388

521

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.9

159.5

386

528

P29

ICPC

Psychological sympt/compl other

3.9

158.7

738

2153

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

8.8

158.0

357

437

C07AA05

ATC

propranolol; systemic

2.9

154.9

1146

4735

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

7.2

153.1

394

590

Z2445

NOMESCO Finland

Psychologist

4.4

152.2

619

1592

F98.8

ICD-10 Finland

Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence

23.7

151.1

220

N05CF01

ATC

zopiclone; oral

3.0

145.4

1034

4136

N06AX21

ATC

duloxetine; oral

4.1

144.5

634

1745

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

6.7

140.9

381

610

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

6.4

140.6

393

658

N05AH03

ATC

olanzapine; systemic

4.2

140.0

598

1603

ZYC01

NOMESCO Finland

Remote contact by phone

5.2

140.0

474

1003

F41.1

ICD-10 Finland

Generalized anxiety disorder

4.0

138.6

618

1722

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.3

135.7

561

1456

N05BA01

ATC

diazepam; systemic, rectal

3.7

134.7

653

1953

Z3231

NOMESCO Finland

Registered nurse

2.5

134.5

1357

6642

P01

ICPC

Feeling anxious/nervous/tense

2.6

130.1

1205

5604

IGY99

NOMESCO Finland

Other psychiatric treatment contact

6.0

127.6

375

668

P03

ICPC

Feeling depressed

2.8

126.1

963

3980

F61.0

ICD-10 Finland

Mixed personality disorders

9.0

122.9

271

316

N05AX12

ATC

aripiprazole; systemic

4.2

122.6

513

1340

F90.1

ICD-10 Finland

Hyperkinetic conduct disorder

+∞

120.1

115

N03AG01

ATC

valproic acid; systemic, rectal

4.2

118.2

496

1297

N03AX16

ATC

pregabalin; oral

3.0

117.4

791

3002

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.9

114.3

340

613

Z2446

NOMESCO Finland

Social worker

3.4

113.1

618

2015

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.3

112.8

459

1164

SPAT1240

SPAT

Therapeutic discussion

2.6

111.3

974

4325

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

5.7

110.2

340

640

F31.8

ICD-10 Finland

Other bipolar affective disorders

6.8

109.2

291

453

P76

ICPC

Depressive disorder

3.3

108.0

605

2005

N06BA02

ATC

dexamfetamine; oral

144.1

106.3

113

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.3

105.0

419

1040

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.9

104.9

365

787

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.1

103.5

435

1133

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

7.1

103.0

265

392

3141A

ICD-9 Finland

Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay

+∞

101.2

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.1

99.2

256

380

SPAT1307

SPAT

Psychosocial counselling and guidance

2.7

97.1

789

3324

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.3

96.4

534

1746

N05CF02

ATC

zolpidem; oral

2.8

95.6

722

2909

N05BA12

ATC

alprazolam; oral

3.6

94.0

465

1390

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.9

91.1

412

1141

F39

ICD-10 Finland

Unspecified mood [affective] disorder

5.7

90.8

276

508

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.9

90.5

409

1132

P99

ICPC

Psychological disorders other

4.9

90.2

312

666

F34.1

ICD-10 Finland

Dysthymia

4.8

90.0

322

713

F40.1

ICD-10 Finland

Social phobias

4.2

89.8

368

932

F99

ICD-10 Finland

Mental disorder, not otherwise specified

5.9

88.5

262

467

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.7

87.2

421

1231

F51.0

ICD-10 Finland

Nonorganic insomnia

2.5

85.4

777

3464

P74

ICPC

Anxiety disorder/anxiety state

3.5

85.3

445

1384

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.1

82.3

346

896

F90.8

ICD-10 Finland

Other hyperkinetic disorders

101.5

82.0

R03AC02

ATC

salbutamol; inhalant

1.9

81.9

2261

16016

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

8.0

81.8

193

250

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

5.6

81.8

253

475

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

5.6

81.3

252

474

Z2221

NOMESCO Finland

Medical doctor

2.1

80.7

1254

7163

N06AB05

ATC

paroxetine; oral

3.9

79.3

354

966

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

5.3

78.0

253

502

F32.1

ICD-10 Finland

Moderate depressive episode

3.0

77.1

491

1756

Z71.8

ICD-10 Finland

Other specified counselling

2.0

76.6

1282

7510

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.8

75.6

199

303

L03

ICPC

Low back symptom/complaint

2.1

75.4

1084

5963

G47.3

ICD-10 Finland

Sleep apnoea

2.6

75.3

612

2547

XA800

NOMESCO Finland

Neuropsychological investigation

4.0

75.1

324

857

F81.3

ICD-10 Finland

Mixed disorder of scholastic skills

11.4

75.0

144

129

R53

ICD-10 Finland

Malaise and fatigue

2.2

75.0

893

4520

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.4

74.6

395

1237

F90

ICD-10 Finland

Hyperkinetic disorders

38.6

74.5

WX110

NOMESCO Finland

Local anesthesy

1.9

74.3

3169

25655

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

8.7

74.3

166

197

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

73.9

1642

10647

N02AX02

ATC

tramadol; systemic, rectal

2.0

73.4

1138

6446

F93.89

ICD-10 Finland

Other childhood emotional disorders

5.3

73.0

236

466

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.0

71.5

310

823

M54.5

ICD-10 Finland

Low back pain

1.9

71.5

1321

7992

N03AE01

ATC

clonazepam; systemic

4.3

70.0

278

680

A02BC02

ATC

pantoprazole; systemic

1.8

69.9

1882

12944

N05BE01

ATC

buspirone; oral

5.9

69.0

203

358

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.6

68.9

210

387

P06

ICPC

Sleep disturbance

2.6

68.4

564

2354

M79.6

ICD-10 Finland

Pain in limb

1.9

68.2

1263

7618

N06AX22

ATC

agomelatine; oral

5.0

67.7

227

467

N03AX12

ATC

gabapentin; oral

2.8

67.4

492

1914

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.5

66.9

344

1051

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.9

66.9

195

340

N07BB01

ATC

disulfiram; oral

4.2

66.2

270

677

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.9

66.1

291

782

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.6

66.1

526

2150

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.4

65.7

179

286

N06AX05

ATC

trazodone; oral

5.7

65.0

196

356

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

64.1

912

4944

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

5.3

64.0

204

396

N05AN01

ATC

lithium; oral

5.0

63.8

214

440

L17

ICPC

Foot/toe symptom/complaint

2.0

62.5

994

5623

F32

ICD-10 Finland

Depressive episode

3.0

62.4

403

1447

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

6.3

62.2

173

284

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

60.8

3269

27364

IGV01

NOMESCO Finland

Psychiatric network contact

6.4

60.5

165

264

K02.1

ICD-10 Finland

Caries of dentine

1.7

59.6

2814

22509

N02BE01

ATC

paracetamol; systemic, rectal

1.8

59.6

3025

24746

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

59.4

2137

15770

SPAT1243

SPAT

Psychiatric/psychological examination

3.2

59.2

339

1118

R51.80

ICD-10 Finland

Headache

2.0

59.0

849

4604

Z3226

NOMESCO Finland

Physiotherapist

2.1

58.7

739

3788

F81.0

ICD-10 Finland

Specific reading disorder

8.8

58.5

129

150

N05AA02

ATC

levomepromazine; systemic

4.4

58.4

224

529

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.4

57.2

301

934

B18.2

ICD-10 Finland

Chronic viral hepatitis C

6.1

56.9

161

270

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

56.2

685

3454

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

56.2

2235

16863

N05AF03

ATC

chlorprothixene; systemic

5.0

56.1

187

382

F81.9

ICD-10 Finland

Developmental disorder of scholastic skills, unspecified

9.5

55.9

118

127

R05

ICPC

Cough

1.9

55.0

1028

6130

IGP01

NOMESCO Finland

Psychiatric family contact

5.4

54.2

171

328

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.4

53.7

279

857

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.1

53.2

217

543

L02

ICPC

Back symptom/complaint

2.3

52.2

520

2382

WX290

NOMESCO Finland

Other blockade of nerve

1.6

51.3

2373

18452

IEV99

NOMESCO Finland

Other psychiatric network intervention

7.0

50.3

128

186

SPAT1389

SPAT

Visit based on need for special support

2.5

49.9

412

1709

L01

ICPC

Neck symptom/complaint

2.1

49.7

619

3134

G44.2

ICD-10 Finland

Tension-type headache

2.1

49.5

603

3025

R06.0

ICD-10 Finland

Dyspnoea

2.0

49.4

699

3734

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

49.2

1130

7172

N01

ICPC

Headache

1.8

49.0

943

5646

N06AA12

ATC

doxepin; systemic

5.1

48.7

161

326

A04

ICPC

Weakness/tiredness general

2.0

48.5

680

3617

F92.0

ICD-10 Finland

Depressive conduct disorder

8.0

48.0

112

143

R74

ICPC

Upper respiratory infection acute

1.6

47.9

1795

13097

F83

ICD-10 Finland

Mixed specific developmental disorders

4.9

47.9

162

336

S18

ICPC

Laceration/cut

1.7

47.3

1261

8358

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

7.1

46.9

118

169

F92.9

ICD-10 Finland

Mixed disorder of conduct and emotions, unspecified

9.0

46.7

101

114

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

46.6

1887

14013

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.7

46.6

138

246

N05CD07

ATC

temazepam; oral

3.9

46.4

203

541

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

46.1

749

4208

SPAT1283

SPAT

Restricted health certificate

1.7

45.8

1420

9804

F82

ICD-10 Finland

Specific developmental disorder of motor function

6.2

45.8

127

208

L12

ICPC

Hand/finger symptom/complaint

2.0

45.2

707

3914

J01DB01

ATC

cefalexin; oral

1.7

45.2

3273

28175

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

45.0

1416

9806

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.9

44.9

301

1099

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

5.2

44.9

145

286

N04BC05

ATC

pramipexole; oral

4.3

44.5

171

405

P19

ICPC

Drug abuse

4.9

44.5

151

315

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

43.9

402

1754

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

43.6

870

5244

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

5.6

43.5

132

242

IBA03

NOMESCO Finland

Psychotherapy evaluation

5.6

43.4

131

239

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.8

43.3

304

1143

C07AB07

ATC

bisoprolol; oral

1.9

43.2

733

4174

M25.5

ICD-10 Finland

Pain in joint

1.7

43.2

1011

6411

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

42.9

1314

9004

N06AX03

ATC

mianserin; oral

4.4

42.5

160

371

F33

ICD-10 Finland

Recurrent depressive disorder

3.8

42.5

186

496

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

6.4

42.4

115

183

R02

ICPC

Shortness of breath/dyspnoea

2.3

42.4

450

2110

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

8.9

42.3

105

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

42.0

2428

19490

T74.1

ICD-10 Finland

Physical abuse

3.5

41.7

209

623

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

41.5

700

3972

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

41.4

531

2709

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.4

41.4

209

627

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.3

41.3

130

249

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

41.3

2419

19436

M03BX02

ATC

tizanidine; oral

1.6

40.6

1990

15301

N06AG02

ATC

moclobemide; oral

4.3

40.5

158

380

ZXE00

NOMESCO Finland

One hour or less

1.6

40.4

1485

10636

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

40.3

255

899

-1

NOMESCO Finland

1.6

40.0

1893

14415

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

40.0

688

3929

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

39.7

661

3728

N05AB03

ATC

perphenazine; systemic, rectal

3.8

39.6

177

481

M79.7

ICD-10 Finland

Fibromyalgia

3.8

39.6

175

471

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

6.6

39.4

104

160

Z07

ICPC

Education problem

4.3

39.4

151

357

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

39.2

1064

7011

D01

ICPC

Abdominal pain/cramps general

1.9

39.2

666

3780

F92.8

ICD-10 Finland

Other mixed disorders of conduct and emotions

11.1

39.1

L28

ICPC

Limited function/disability (L)

2.5

39.0

320

1316

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.5

38.7

118

218

Z00.0

ICD-10 Finland

General medical examination

1.8

38.7

801

4862

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

38.6

757

4514

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

38.6

1685

12551

R21

ICPC

Throat symptom/complaint

1.6

38.3

1460

10512

D11

ICPC

Diarrhoea

1.9

37.8

660

3783

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

7.9

37.5

111

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.7

37.1

130

281

M01AE02

ATC

naproxen; oral, rectal

1.5

37.0

2330

18807

P15

ICPC

Chronic alcohol abuse

4.0

36.8

153

390

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

36.8

1307

9226

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

36.7

718

4269

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

36.5

753

4555

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

36.4

686

4026

3140B

ICD-9 Finland

Hyperkinetic syndrome of childhood, Attention deficit disorder

+∞

36.4

F41.00

ICD-10 Finland

Moderate panic disorder

3.8

36.3

162

440

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

36.3

573

3161

F31

ICD-10 Finland

Bipolar affective disorder

5.0

36.2

119

240

F60.8

ICD-10 Finland

Other specific personality disorders

7.7

36.1

111

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

35.7

315

1347

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.1

35.7

211

710

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.4

35.6

313

1334

F60.5

ICD-10 Finland

Anankastic personality disorder

5.9

35.5

102

176

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.7

35.2

258

995

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

4.2

35.2

140

343

Z72.2

ICD-10 Finland

Drug use

5.6

35.1

105

190

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

3.6

35.1

166

473

R06AE07

ATC

cetirizine; oral

1.5

35.1

1844

14226

SPAT1301

SPAT

No procedures

1.6

35.0

1182

8214

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

34.8

2453

20162

SPAT1310

SPAT

Counselling related to known health issue

1.6

34.8

1353

9733

WX002

NOMESCO Finland

Sedation and analgesia

2.0

34.6

498

2650

S29

ICPC

Skin symptom/complaint other

1.9

34.6

606

3468

R5599

NOMESCO Finland

Other rehabilitation service

3.8

34.5

151

403

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

34.5

1214

8519

N06BA07

ATC

modafinil; oral

11.3

34.2

L15

ICPC

Knee symptom/complaint

1.8

34.2

703

4238

P01AB01

ATC

metronidazole; oral, rectal

1.6

34.1

1220

8589

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.3

34.1

348

1596

F81.8

ICD-10 Finland

Other developmental disorders of scholastic skills

8.0

34.0

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

33.8

1010

6788

A01

ICPC

Pain general/multiple sites

2.5

33.8

290

1221

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

33.7

592

3388

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

33.7

887

5755

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

33.7

567

3195

R5140

NOMESCO Finland

Monitoring the use of the aid

2.7

33.7

248

959

N06AA06

ATC

trimipramine; systemic

5.5

33.6

102

188

SPAT1234

SPAT

Support of social functional capacity

3.4

33.6

167

495

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

33.5

1362

9879

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

33.4

1167

8160

IAB03

NOMESCO Finland

Neuropsychiatric consultation

31.5

33.3

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

33.3

225

825

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

33.2

415

2085

SPAT1260

SPAT

Consultation of another employee

1.8

33.1

656

3905

G43.9

ICD-10 Finland

Migraine, unspecified

2.1

33.0

394

1942

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

32.8

252

996

EBA00

NOMESCO Finland

Extraction of tooth

1.5

32.7

1542

11556

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.1

32.3

185

609

S06.0

ICD-10 Finland

Concussion

1.9

32.2

495

2694

F98.9

ICD-10 Finland

Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence

7.2

32.2

110

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.3

32.2

166

507

A05

ICPC

Feeling ill

1.8

32.2

567

3245

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

32.1

561

3199

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.7

32.0

224

841

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

31.9

478

2579

E66.8

ICD-10 Finland

Other obesity

2.6

31.8

237

924

P24

ICPC

Specific learning problem

4.6

31.6

113

250

R05

ICD-10 Finland

Cough

1.8

31.5

653

3936

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.0

31.4

103

208

N06AB08

ATC

fluvoxamine; oral

4.9

31.4

106

221

IEY01

NOMESCO Finland

Psychoeducation, individual

4.9

31.4

106

221

F33.8

ICD-10 Finland

Other recurrent depressive disorders

5.6

31.4

171

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

31.4

743

4664

L08

ICPC

Shoulder symptom/complaint

1.9

31.3

486

2655

ZY000

NOMESCO Finland

Hospital inpatient

3.7

31.2

140

383

A03

ICPC

Fever

1.6

31.1

1049

7245

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

6.5

30.9

128

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

30.7

875

5785

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

30.6

987

6737

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.6

30.5

144

411

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

5.7

30.3

158

AA1AD

NOMESCO Finland

CT of head and brain

1.9

30.3

468

2551

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

6.0

30.1

144

R03BA02

ATC

budesonide; inhalant

1.7

30.1

658

4028

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

4.0

30.0

122

306

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

30.0

1254

9100

M79.1

ICD-10 Finland

Myalgia

1.9

29.5

504

2845

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

29.3

3169

27953

Z06

ICPC

Unemployment problem

7.0

29.2

105

M54.2

ICD-10 Finland

Cervicalgia

2.4

29.2

255

1083

SPAT1312

SPAT

General health counselling

1.5

29.2

1566

11979

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

29.1

820

5393

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

29.1

513

2931

F95.2

ICD-10 Finland

Combined vocal and multiple motor tic disorder [de la Tourette]

14.5

29.0

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

4.9

28.9

201

R52.2

ICD-10 Finland

Other chronic pain

3.6

28.7

133

374

N06AA09

ATC

amitriptyline; systemic

2.8

28.7

192

702

F84.9

ICD-10 Finland

Pervasive developmental disorder, unspecified

7.4

28.6

SPAT1216

SPAT

Assessment of functional ability

2.2

28.6

313

1481

SPAT1254

SPAT

Administration of medicine

1.7

28.4

668

4175

R42

ICD-10 Finland

Dizziness and giddiness

1.8

28.2

502

2875

D10

ICPC

Vomiting

1.9

28.1

482

2722

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.4

28.0

143

434

F84.8

ICD-10 Finland

Other pervasive developmental disorders

12.5

27.9

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.0

27.7

381

1985

A29

ICPC

General symptom/complaint other

2.0

27.7

358

1819

A02BC05

ATC

esomeprazole; systemic

1.6

27.6

983

6848

H03AA01

ATC

levothyroxine sodium; systemic

1.7

27.5

596

3630

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

27.4

813

5411

M01AB05

ATC

diclofenac; systemic, rectal

1.4

27.3

1908

15319

IEP99

NOMESCO Finland

Other psychiatric family intervention

5.1

27.3

171

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

27.3

336

1676

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

27.2

805

5353

IAZ98

NOMESCO Finland

Other internal psychiatric consultation

12.3

27.1

ZXY60

NOMESCO Finland

2-person team, nurses

4.8

27.0

190

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

6.5

27.0

110

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

26.8

355

1820

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

6.8

26.7

101

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

26.6

374

1964

R11

ICD-10 Finland

Nausea and vomiting

2.0

26.6

360

1865

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

26.4

256

1145

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

26.2

553

3339

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

26.1

279

1306

R07

ICPC

Sneezing/nasal congestion

1.9

26.1

443

2491

ZXY02

NOMESCO Finland

Neuropsychologist

7.7

26.0

P23

ICPC

Adolescent behaviour sympt/compl

4.6

25.9

199

K04.0

ICD-10 Finland

Pulpitis

1.8

25.8

500

2937

F50.9

ICD-10 Finland

Eating disorder, unspecified

3.2

25.7

139

441

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

25.6

810

5464

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

25.6

267

1237

N05BA02

ATC

chlordiazepoxide; systemic

5.4

25.6

146

N17

ICPC

Vertigo/dizziness

2.0

25.5

339

1742

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.8

25.5

499

2942

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.0

25.4

154

529

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

6.6

25.4

101

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

6.1

25.3

116

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

25.3

283

1351

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.6

25.2

115

320

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

25.1

393

2145

R4110

NOMESCO Finland

Physiotherapy

1.6

25.1

746

4953

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

25.1

218

925

IEP01

NOMESCO Finland

Psychoeducation, family

9.0

25.0

WZA90

NOMESCO Finland

Other doctors statement

1.5

25.0

1062

7669

R52.9

ICD-10 Finland

Pain, unspecified

2.1

24.9

298

1466

F32.8

ICD-10 Finland

Other depressive episodes

3.4

24.9

122

360

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.0

24.8

326

1668

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.9

24.7

155

545

N03AX11

ATC

topiramate; oral

2.9

24.6

158

562

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.2

24.6

228

F93.9

ICD-10 Finland

Childhood emotional disorder, unspecified

5.9

24.6

117

SPAT1272

SPAT

Drug screening

5.6

24.5

129

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

4.0

24.5

101

258

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

24.5

585

3661

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

5.1

24.4

154

A02BC03

ATC

lansoprazole; oral

1.7

24.4

558

3445

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

4.9

24.4

167

K04.08

ICD-10 Finland

Other specified pulpit

1.9

24.4

357

1904

N06AX18

ATC

reboxetine; oral

7.6

24.3

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

24.3

585

3668

KMAK

NOMESCO Finland

1.4

24.3

2080

17193

R4120

NOMESCO Finland

Occupational therapy

2.4

24.1

211

898

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

4.7

24.0

179

R03BA05

ATC

fluticasone; inhalant

1.6

24.0

729

4865

R06.5

ICD-10 Finland

Mouth breathing

2.1

24.0

287

1411

R01AD09

ATC

mometasone; nasal

1.4

23.9

1687

13455

L16

ICPC

Ankle symptom/complaint

1.8

23.8

466

2744

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

23.7

624

4007

F80.2

ICD-10 Finland

Receptive language disorder

4.4

23.7

199

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

23.5

694

4593

R06AX27

ATC

desloratadine; oral

1.4

23.5

1262

9546

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

6.4

23.5

A28

ICPC

Limited function/disability NOS

2.5

23.5

189

769

E0000UV

ATC

1.4

23.4

1548

12182

R00.2

ICD-10 Finland

Palpitations

2.1

23.4

285

1410

SPAT1058

SPAT

PEF monitoring instruction

2.1

23.4

267

1287

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

23.4

255

1203

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.5

23.4

184

Z00.8

ICD-10 Finland

Other general examinations

1.9

23.3

341

1817

N76.0

ICD-10 Finland

Acute vaginitis

1.9

23.3

384

2137

SPAT1396

SPAT

Meeting with multidisciplinary group of experts

3.7

23.3

105

290

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.8

23.3

442

2577

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.6

23.2

107

301

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.7

23.2

104

286

K08.3

ICD-10 Finland

Retained dental root

2.5

23.0

180

723

ZXD20

NOMESCO Finland

Day surgery

1.8

22.9

406

2313

N06AX17

ATC

milnacipran; oral

6.3

22.9

A97

ICPC

No disease

1.6

22.8

676

4476

F91.9

ICD-10 Finland

Conduct disorder, unspecified

7.3

22.8

R96

ICPC

Asthma

2.0

22.7

287

1444

T82

ICPC

Obesity

2.6

22.7

174

689

R4140

NOMESCO Finland

Psychotherapy

4.8

22.7

163

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.3

22.7

118

365

ZXY80

NOMESCO Finland

Doctor in multidisciplinary team

5.1

22.6

142

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.6

22.6

174

691

A02BC01

ATC

omeprazole; systemic

1.6

22.6

654

4302

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

4.4

22.5

191

Z01.7

ICD-10 Finland

Laboratory examination

1.8

22.5

388

2188

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

22.4

308

1602

IER01

NOMESCO Finland

Psychoeducation, group

4.4

22.4

188

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

22.3

861

6065

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

8.1

22.2

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.4

22.2

111

333

SPAT1395

SPAT

Health check-up of persons outside student and working life

3.4

22.1

108

318

P27

ICPC

Fear of mental disorder

3.5

22.1

107

313

F91.3

ICD-10 Finland

Oppositional defiant disorder

23.8

22.0

N05BA06

ATC

lorazepam; systemic, sublingual

3.0

22.0

133

456

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.4

22.0

182

X78

ICD-10 Finland

Intentional self-harm by sharp object

4.3

22.0

196

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

22.0

1034

7599

L86

ICPC

Back syndrome with radiating pain

2.5

21.9

172

689

P22

ICPC

Child behaviour symptom/complaint

3.5

21.9

105

305

S21

ICPC

Skin texture symptom/complaint

1.8

21.9

409

2371

N07BA03

ATC

varenicline; oral

2.3

21.8

200

872

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

21.8

303

1585

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

21.7

367

2060

IEY17

NOMESCO Finland

Neuropsychiatric coaching

80.0

21.6

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.7

21.6

154

587

M01AH05

ATC

etoricoxib; oral

1.4

21.5

1600

12806

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

7.8

21.3

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

21.3

165

657

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

5.5

21.2

115

J01FF01

ATC

clindamycin; systemic

1.5

21.2

767

5317

H01

ICPC

Ear pain/earache

1.6

21.2

598

3904

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

7.5

21.2

F88

ICD-10 Finland

Other disorders of psychological development

7.9

21.1

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

4.3

21.1

181

F41

ICD-10 Finland

Other anxiety disorders

3.1

21.0

120

395

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

21.0

1896

15653

Z29

ICPC

Social problem NOS

2.8

21.0

136

487

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

6.0

21.0

IEY03

NOMESCO Finland

Vocational rehabilitation

7.0

21.0

S10

ICPC

Boil/carbuncle

2.3

21.0

204

915

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

20.9

170

698

F50.2

ICD-10 Finland

Bulimia nervosa

4.0

20.8

216

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

8.0

20.8

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

6.2

20.7

X58

ICD-10 Finland

Exposure to other specified factors

1.6

20.7

581

3786

F34.0

ICD-10 Finland

Cyclothymia

7.0

20.7

Z72.0

ICD-10 Finland

Tobacco use

3.1

20.7

113

363

F80.8

ICD-10 Finland

Other developmental disorders of speech and language

6.5

20.7

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

20.6

345

1929

K85

ICPC

Elevated blood pressure

2.3

20.5

191

840

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.4

20.5

173

723

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

20.4

410

2427

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

20.4

435

2622

K04.1

ICD-10 Finland

Necrosis of pulp

1.8

20.4

398

2334

F43.00

ICD-10 Finland

Acute stress reaction mild

2.7

20.3

141

527

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

3.9

20.3

221

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

7.1

20.1

J01AA02

ATC

doxycycline; systemic

1.4

20.1

2097

17677

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

7.3

20.0

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

20.0

389

2283

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

6.2

20.0

IGY02

SPAT

5.1

19.9

124

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

19.8

2568

22387

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

19.8

370

2144

A27

ICPC

Fear of other disease NOS

2.5

19.7

156

630

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

19.7

470

2929

Z08

ICPC

Social welfare problem

4.3

19.7

170

P18

ICPC

Medication abuse

5.0

19.7

126

A11

ICPC

Chest pain NOS

2.4

19.7

174

746

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.8

19.6

132

485

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

19.5

546

3549

SPAT1281

SPAT

Other administrative function

1.8

19.4

327

1831

A92

ICPC

Allergy/allergic reaction NOS

2.2

19.3

205

955

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.4

19.2

289

H02

ICPC

Hearing complaint

2.3

19.2

176

767

J02AC01

ATC

fluconazole; systemic

1.4

19.1

1252

9740

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

19.1

232

1149

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

19.1

197

910

F80.1

ICD-10 Finland

Expressive language disorder

3.4

19.1

270

F81.1

ICD-10 Finland

Specific spelling disorder

10.9

19.0

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.7

19.0

425

2597

P20

ICPC

Memory disturbance

5.2

19.0

114

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.5

19.0

153

RT420

NOMESCO Finland

8.6

19.0

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

8.6

19.0

ZXA10

NOMESCO Finland

Bilateral

1.6

19.0

486

3085

J01DA01

ATC

[U] cefalexin; systemic

1.3

18.9

2049

17306

Z25

ICPC

Assault/harmful event problem

3.6

18.9

246

ZXY61

NOMESCO Finland

2-person team, special workers

6.5

18.8

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

18.8

262

1370

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(1001926) Buprenorphine [Presence] in Urine by Screen method

1687

3966

5.81

307.65

3.4

2.2

—

(3016879) Cocaine [Presence] in Urine

1795

4755

5.24

307.65

3.4

2.2

—

(3028707) Methadone [Presence] in Urine by Screen method

1447

1991

9.66

307.65

3.5

3.0

—

(3009508) Creatinine [Moles/volume] in Urine

2038

8219

3.43

307.65

4.2

3.7

mmol/l

8.7

8.9

0.56

1788

7330

(3028300) Cannabinoids [Presence] in Urine

1837

5175

4.94

307.65

3.4

2.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2251

6940

4.98

307.65

2.1

1.8

1.5

1.3

12.86

2042

6330

(3027008) Opiates [Presence] in Urine

1830

5166

4.92

307.65

3.3

2.0

—

(3027944) Amphetamines [Presence] in Urine

1765

5097

4.72

307.65

3.4

2.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

504

615

8.88

307.65

2.0

2.5

—

(3000764) Benzodiazepines [Presence] in Urine

1827

5130

4.95

307.65

3.4

2.1

—

(3011288) Drugs identified in Urine by Screen method

1729

3451

7.01

307.65

4.8

2.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4296

30580

3.63

244.42

4.6

3.8

pmol/l

14.3

14.4

0.46

4050

28210

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1934

9542

2.62

222.43

1.8

1.6

pmol/l

98.9

98.4

0.17

1107

5412

(3044889) 12 lead EKG panel

3119

19304

2.56

220.48

2.8

2.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3588

23909

2.67

214.23

6.0

6.2

u/l

77.0

76.9

0.02

3391

22551

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2227

11972

2.50

210.95

3.5

3.3

u/l

30.8

30.1

0.20

2111

11405

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4592

35173

4.28

209.83

5.6

4.3

mu/l

1.7

1.8

1.74

4421

33394

(3015377) Calcium [Moles/volume] in Serum or Plasma

1767

8644

2.57

203.26

2.2

2.7

mmol/l

2.3

2.4

0.99

1595

7871

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2337

13058

2.43

200.54

6.2

6.7

mmol/l

1.2

1.55

2029

11202

(44816559) Phosphatidylethanol [Mass/volume] in Blood

490

1130

4.63

193.26

1.5

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4595

35774

4.06

191.92

11.6

8.7

mmol/l

139.6

139.5

2.02

4490

34603

(3023103) Potassium [Moles/volume] in Serum or Plasma

4600

35851

4.08

191.53

11.6

8.8

mmol/l

3.9

7.42

4475

34554

(3019150) Specific gravity of Urine by Refractometry

1637

8116

2.47

178.81

3.5

3.0

kg/l

1.0

1.45

129

1206

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2127

11844

2.34

178.36

5.9

6.6

mmol/l

1.2

3.49

1965

10931

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3818

27852

2.46

160.73

4.1

2.9

u/l

33.6

33.2

0.22

3669

26763

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4167

31779

2.71

157.23

3.7

2.7

mmol/l

5.6

5.5

2.92

3908

29831

(3021960) Folate [Moles/volume] in Serum or Plasma

1155

5173

2.56

153.69

1.5

1.4

nmol/l

18.8

19.7

1.78

1044

4686

(3019309) Folate [Moles/volume] in Red Blood Cells

847

3318

2.83

146.54

1.7

1.6

nmol/l

1051.9

1149.2

2.57

683

2586

(4198724)

287

541

5.49

142.53

2.5

3.0

—

(3018418) pH of Serum or Plasma

1394

7210

2.26

131.39

3.1

3.7

7.4

1.24

252

1404

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2235

14030

2.03

125.40

2.7

2.4

nmol/l

68.0

69.3

1.40

2086

13259

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2286

14652

1.99

119.03

4.9

5.3

umol/l

10.1

11.0

2.68

2109

13657

(3024561) Albumin [Mass/volume] in Serum or Plasma

1879

11344

2.01

115.08

4.3

5.3

g/l

38.2

37.8

2.22

1715

10619

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1458

8159

2.08

109.03

2.2

2.4

mg/l

2.5

2.6

0.97

1235

7110

(3013707) Erythrocyte sedimentation rate by Westergren method

3425

25651

1.99

108.63

3.8

3.6

mm/h

7.6

7.5

0.20

3196

24055

(3013826) Glucose [Moles/volume] in Serum or Plasma

2664

18380

1.91

107.68

4.6

4.5

mmol/l

6.1

6.2

2.12

2472

16335

(3013650) Neutrophils [#/volume] in Blood by Automated count

3024

21773

1.93

107.06

8.0

8.9

e9/l

3.9

0.26

2608

19076

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4740

40743

3.53

105.73

9.7

7.5

u/l

28.6

27.4

2.66

4632

39541

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1276

6876

2.11

104.93

2.3

2.1

u/l

187.9

263.8

1.88

1221

6551

(3015736) pH of Urine

2198

14341

1.91

104.36

3.5

2.8

—

6.2

—

(3042517) Benzodiazepines panel - Urine

119

121

9.92

102.58

3.0

2.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4044

32593

2.14

98.65

9.3

7.2

ml/min/173m2

104.0

102.2

7.21

3193

25353

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

979

4878

2.22

97.51

1.6

1.5

pmol/l

28351550.8

27748507.7

0.01

843

4303

(3006315) Basophils [#/volume] in Blood

2717

19341

1.84

94.66

5.7

6.6

e9/l

0.0

1.25

2326

17005

(3013115) Eosinophils [#/volume] in Blood

2790

20030

1.84

94.48

6.2

7.0

e9/l

0.2

0.39

2440

17916

(42870588) Differential panel, method unspecified - Blood

1957

12594

1.87

94.32

5.4

6.8

—

(3001604) Monocytes [#/volume] in Blood

2708

19295

1.83

93.67

5.7

6.6

e9/l

0.5

0.00

2326

16998

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1551

9318

1.93

91.88

2.7

2.6

u/l

54.4

55.6

0.48

1403

8652

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2848

20740

1.82

90.31

3.4

2.9

ug/l

66.0

69.7

0.89

2686

19712

(3036481) Cortisol [Moles/volume] in Serum or Plasma

799

3783

2.29

89.40

2.0

2.1

nmol/l

364.5

375.5

0.91

742

3509

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1920

12443

1.85

89.20

1.5

1.4

u/ml

2.0

1.9

0.15

445

3283

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

774

3658

2.29

86.79

1.9

2.3

mmol/l

2.4

0.92

655

3157

(3019198) Lymphocytes [#/volume] in Blood

2781

20294

1.79

85.65

5.7

6.5

e9/l

2.1

2.0

2.79

2441

18263

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3559

27997

1.87

84.98

4.1

3.5

mmol/mol

36.4

36.6

0.62

3326

26671

(3013512) EKG study

1068

5769

2.05

84.95

2.6

2.3

—

(3022096) Basophils/100 leukocytes in Blood

2495

17669

1.78

84.87

5.7

6.8

0.7

0.58

2328

16669

(3019069) Monocytes/100 leukocytes in Blood

2579

18452

1.78

84.58

5.8

6.8

7.9

8.1

1.93

2422

17498

(3006504) Eosinophils/100 leukocytes in Blood

2564

18319

1.78

84.45

5.6

6.6

2.8

0.04

2391

17257

(3021589) Normoblasts [#/volume] in Blood

2458

17584

1.74

78.46

7.9

8.3

e9/l

0.0

1.13

1968

14364

(3018010) Neutrophils/100 leukocytes in Blood

2630

19217

1.73

77.42

5.5

6.3

54.3

54.9

1.78

2465

18249

(3007164) IgA [Mass/volume] in Serum or Plasma

1675

10794

1.80

76.47

1.5

g/l

2.0

0.54

938

6794

(3002030) Lymphocytes/100 leukocytes in Blood

2653

19505

1.72

75.70

5.7

6.5

31.4

31.1

0.80

2484

18474

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1045

5921

1.94

71.03

1.3

iu/ml

23.6

19.3

0.34

237

1638

(3009466) Valproate [Moles/volume] in Serum or Plasma

236

690

3.49

65.86

4.6

6.0

umol/l

361.7

388.6

1.86

209

614

(40758558) Short blood count panel - Blood

1428

9196

1.74

62.85

5.9

7.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

767

4087

2.01

61.48

2.4

g/l

2.6

2.5

1.29

698

3817

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

961

5526

1.89

61.47

1.3

u/ml

5.0

8.3

1.52

366

2322

(3002582) Erythrocytes [#/volume] in Urine

1458

9529

1.72

60.40

3.2

3.0

e6/l

71.3

80.6

0.11

1090

7113

(3022948) Iron [Moles/volume] in Serum or Plasma

823

4550

1.94

59.10

2.5

2.4

umol/l

15.1

14.9

0.32

772

4268

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4525

40029

2.14

58.18

11.9

9.2

mg/l

19.0

20.1

1.57

3454

29525

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1973

14082

1.63

57.57

2.7

2.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3979

33830

1.77

56.95

3.6

3.0

mmol/l

2.9

2.8

1.10

3729

32161

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2103

15360

1.60

55.08

2.9

2.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

642

3367

2.01

53.32

2.5

2.1

nmol/l

12.0

11.8

0.16

550

3028

(3018095) Leukocytes [#/volume] in Urine

1721

12045

1.62

53.31

3.7

3.4

e6/l

60.6

57.3

0.06

1169

7752

(3030467) Casts [#/volume] in Urine by Automated count

1319

8687

1.68

51.64

3.1

2.9

e6/l

0.3

0.2

0.30

961

6373

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

682

3703

1.95

51.12

2.6

2.5

24.4

24.5

0.07

607

3270

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

158

426

3.75

49.73

10.0

11.8

mmol/l

0.6

0.07

137

392

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3940

33812

1.69

49.58

3.5

2.9

mmol/l

4.6

4.7

2.59

3716

32391

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

569

2958

2.01

48.18

2.4

2.6

u/l

30.0

53.5

0.83

485

2545

(3002385) Erythrocyte distribution width [Ratio]

4138

36082

1.74

47.92

15.0

11.5

13.2

0.88

4075

35333

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3905

33543

1.66

47.67

3.4

2.9

mmol/l

1.3

1.4

27.58

3661

32075

(36304419) Bacteria [Presence] in Urine

1315

8825

1.64

47.10

3.1

2.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1240

8237

1.64

46.10

2.6

2.3

ng/l

12.5

66.3

0.84

483

3001

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

135

345

3.94

45.85

2.0

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

680

3819

1.88

45.67

6.4

7.7

mmol/l

1.1

1.18

642

3614

(3012095) Magnesium [Moles/volume] in Serum or Plasma

717

4099

1.85

45.51

4.6

5.3

mmol/l

0.8

0.41

666

3866

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1104

7156

1.67

45.02

1.6

mmol/l

1.6

1.4

5.59

953

6432

(3000850) Epithelial cells [#/volume] in Urine

1020

6498

1.69

44.34

2.6

2.5

e6/l

8.6

7.8

0.76

885

5670

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

735

4266

1.82

44.33

2.8

2.9

ng/l

310.4

625.1

1.30

318

2040

(3026782) Osmolality of Urine

969

6114

1.70

43.58

2.8

2.5

mosm/kgh2o

559.9

573.0

0.76

823

5247

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

519

2716

1.99

42.92

2.8

3.5

pmol/l

4.9

4.7

1.27

461

2477

(3033658) Prothrombin time (PT) actual/Normal

1194

7989

1.62

42.60

4.2

4.4

95.7

94.1

1.71

1159

7773

(3032080) INR in Blood by Coagulation assay

1278

8726

1.60

41.80

4.2

4.6

inr

1.0

1.1

3.21

509

3102

(3037522) Nuclear Ab [Titer] in Serum

880

5468

1.71

41.69

1.5

1.4

titre

439.7

531.4

0.73

137

965

(40761511) CBC panel - Blood by Automated count

4647

42386

2.07

41.39

10.9

8.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2944

24125

1.49

40.27

4.2

3.6

e6/l

164.0

891.5

3.11

266

(40768797) Stomach Pathology biopsy report

620

3512

1.85

40.22

1.2

—

(36660697) Celiac disease serology panel - Serum

760

4593

1.75

39.61

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

629

3609

1.82

39.08

1.6

mu/l

339.9

317.9

0.59

563

3248

(3037467) Urinalysis macro (dipstick) panel - Urine

3084

25600

1.49

38.88

4.0

3.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

632

3661

1.80

37.99

3.0

3.5

umol/l

5.6

6.3

0.61

526

3087

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3721

32189

1.54

37.81

3.2

2.7

mmol/l

1.3

1.2

8.05

3486

30824

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

229

4.29

37.56

3.5

3.0

umol/l

213.5

196.6

0.12

111

(3007461) Platelets [#/volume] in Blood

4935

46448

3.45

36.82

18.4

13.5

e9/l

270.1

262.1

16.93

4840

45253

(3022217) INR in Platelet poor plasma by Coagulation assay

364

1781

2.10

36.03

6.2

8.3

inr

1.1

0.14

351

(3035941) MCH [Entitic mass]

4937

46516

3.44

35.99

18.3

13.4

29.8

0.15

4903

45964

(3026361) Erythrocytes [#/volume] in Blood

4937

46525

3.43

35.79

18.3

13.4

e12/l

4.7

4.6

5.48

4824

45274

(3024731) MCV [Entitic volume]

4936

46512

3.41

35.75

18.3

13.4

88.8

88.7

0.26

4902

45960

(3019225) pH of Specimen

406

2078

2.01

35.54

3.1

3.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

778

4866

1.68

35.46

2.8

2.7

e6/l

4.5

3.8

0.81

399

2507

(3010813) Leukocytes [#/volume] in Blood

4937

46549

3.41

35.27

18.4

13.5

e9/l

6.9

6.8

2.11

4829

45275

(3000963) Hemoglobin [Mass/volume] in Blood

4937

46552

3.40

35.21

18.5

13.5

g/l

138.4

137.5

5.14

4903

45996

(3023368) Bacteria identified in Blood by Culture

949

6258

1.61

35.05

3.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

488

2755

1.83

31.66

1.5

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

654

4017

1.70

31.65

1.3

iu/ml

89.7

150.5

5.03

197

1494

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

104

289

3.61

31.39

1.8

iu/ml

2041171.1

1808777.6

0.07

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

238

1042

2.32

30.99

2.2

1.8

pmol/l

186.8

198.8

0.83

229

998

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

657

4088

1.67

30.19

1.8

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

405

2198

1.89

29.72

8.3

8.8

mmol/l

1.4

0.26

380

2080

(3026008) Bacteria identified in Urine by Culture

1204

8657

1.49

29.40

2.5

2.2

—

(3048689) Calprotectin [Mass/mass] in Stool

1008

6999

1.53

29.06

2.3

2.9

ug/g

97.9

115.3

0.85

722

5566

(3014576) Chloride [Moles/volume] in Serum or Plasma

464

2652

1.80

28.82

7.8

8.1

mmol/l

104.8

104.9

0.16

455

2601

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

473

2721

1.79

28.74

4.2

3.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

767

5019

1.60

28.71

2.7

2.6

e6/l

0.9

1.0

0.32

389

2667

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1275

9338

1.47

28.16

2.5

2.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1073

7609

1.50

27.82

2.1

mg/l

0.8

1.0

1.09

709

5214

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.87

27.24

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1183

8617

1.46

26.64

1.9

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

346

1856

1.90

26.26

3.1

3.3

mmol/l

1.2

0.25

291

1606

(3021447) Carbon dioxide [Partial pressure] in Venous blood

502

3015

1.71

26.15

6.1

kpa

5.9

0.17

481

2925

(3042936) Bacteria identified in Isolate by Culture

623

3960

1.63

26.11

1.8

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

651

4211

1.60

25.36

1.8

1.6

—

(3002032) Base excess in Venous blood by calculation

496

2994

1.70

25.33

6.2

6.1

mmol/l

1.2

1.6

1.41

401

2422

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

415

2382

1.78

25.33

5.3

5.4

kpa

5.1

1.11

391

2270

(3009343) pH of Capillary blood

412

2374

1.78

24.80

5.3

5.4

7.4

0.63

208

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

444

2615

1.74

24.77

2.9

3.2

g/l

0.2

0.19

404

2460

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

171

4.02

24.56

1.5

2.5

umol/l

15.3

15.6

0.08

171

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1046

7545

1.46

24.49

2.3

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

446

2650

1.73

24.09

1.7

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

404

2336

1.77

24.02

5.4

5.5

mmol/l

1.0

1.1

0.21

269

1642

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

316

1696

1.90

23.92

2.1

1.7

nmol/l

36.8

38.5

0.55

305

1679

(3000991) Gas panel - Venous blood

461

2798

1.69

23.00

9.8

9.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

619

4051

1.58

22.81

2.5

3.3

29.6

29.8

0.48

601

3931

(3013139) Helicobacter pylori Ag [Presence] in Stool

388

2256

1.76

22.60

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

440

2655

1.70

22.42

5.8

5.9

kpa

5.1

5.0

0.25

421

2576

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

447

2709

1.69

22.41

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

285

1516

1.91

22.17

1.2

1.3

u/ml

0.3

1.0

1.60

111

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

480

7245

0.62

21.85

1.4

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1101

8167

1.42

21.84

3.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

554

3573

1.60

21.68

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

541

3474

1.60

21.55

3.2

3.4

ng/l

569.1

603.1

0.07

380

2628

(21494755) Public health laboratory ask at order entry panel

447

6803

0.61

20.99

1.2

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

530

3408

1.60

20.97

1.5

iu/l

13.0

15.2

1.48

411

2796

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

363

2115

1.75

20.97

1.4

1.6

mg/l

3.2

3.7

0.88

279

1365

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

545

3540

1.58

20.65

2.1

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1929

15790

1.33

20.40

2.0

1.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

433

2671

1.66

20.25

2.2

au/ml

23.7

19.1

0.33

231

(3020191) Ethanol [Moles/volume] in Serum or Plasma

118

458

2.58

20.06

1.6

promille

1.5

1.3

0.46

346

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

240

1248

1.94

19.98

1.6

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

166

758

2.20

19.61

3.1

3.4

nmol/l

25.3

24.3

0.43

158

737

(40760892) CBC W Ordered Manual Differential panel - Blood

1252

9652

1.37

19.43

4.0

4.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

374

2244

1.70

19.42

6.7

6.5

mmol/l

23.8

24.0

0.55

354

2129

(3035350) Ketones [Presence] in Urine by Test strip

2199

18437

1.31

19.27

3.2

3.0

estimate

0.0

1.08

474

3725

(3009261) Glucose [Presence] in Urine by Test strip

2211

18553

1.31

19.26

3.2

3.0

estimate

0.0

0.26

493

3775

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

173

811

2.14

19.14

2.6

2.8

ug/l

525.1

348.7

0.35

156

717

(3023183) Ammonium ion [Moles/volume] in Plasma

138

592

2.34

18.92

2.9

3.0

umol/l

33.1

32.3

0.17

117

530

(3021440) Promyelocytes/100 leukocytes in Blood

411

2554

1.64

18.64

3.7

4.7

0.1

0.60

589

(3021601) Nitrite [Presence] in Urine by Test strip

2192

18452

1.31

18.33

4.3

4.1

estimate

0.0

0.33

499

3895

(3016650) Hepatitis A virus Ab [Presence] in Serum

174

832

2.10

18.30

1.2

1.1

—

(3036180) Methadone [Presence] in Urine

8.77

18.24

1.6

2.6

—

(3000494) Fungus identified in Specimen by Culture

550

3678

1.53

18.23

1.4

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

155

710

2.19

18.19

1.3

1.4

ug/g

319.1

333.3

0.30

346

(3007463) Buprenorphine [Presence] in Urine

5.65

17.70

6.1

5.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

216

1133

1.92

17.55

1.8

1.6

—

(3016502) Oxygen saturation in Arterial blood

309

1810

1.73

17.50

8.8

10.3

95.6

96.8

1.58

304

1737

(3027801) Oxygen [Partial pressure] in Arterial blood

345

2084

1.68

17.45

8.2

9.4

kpa

13.1

14.5

4.75

333

1987

(3003396) Base excess in Arterial blood by calculation

346

2092

1.68

17.44

8.2

9.4

mmol/l

0.7

0.5

0.28

263

1552

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

345

2085

1.68

17.42

8.2

9.4

kpa

5.1

5.0

0.81

334

1984

(3017181) Myelocytes/100 leukocytes in Blood

418

2656

1.60

17.30

3.8

4.6

0.8

0.01

630

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

303

1771

1.73

17.30

5.1

5.3

ng/l

68.9

68.7

0.02

270

1658

(3009214) Lutropin [Units/volume] in Serum or Plasma

439

2825

1.58

17.22

1.5

1.6

u/l

6.8

7.4

0.60

324

2254

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

225

1206

1.88

17.12

1.8

2.1

ug/l

4.3

7.4

3.11

193

1045

(3025159) Blasts/100 leukocytes in Blood

391

2457

1.62

16.93

3.8

4.8

0.0

0.2

0.59

508

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

394

2484

1.61

16.84

1.2

au/ml

27.9

38.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

290

1692

1.73

16.66

8.5

10.3

g/l

128.6

125.7

1.63

281

1626

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

267

1522

1.77

16.64

1.6

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

1238

9723

1.34

16.60

3.4

3.2

estimate

0.0

1.74

488

3791

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

147

2872

0.49

16.49

1.3

1.5

—

(3012501) Base excess in Blood by calculation

142

655

2.17

16.42

3.6

mmol/l

1.9

1.8

0.06

369

(3010421) pH of Blood

155

745

2.09

16.12

3.5

7.4

1.07

139

644

(3009542) Hematocrit [Volume Fraction] of Blood

4399

41153

1.44

15.73

13.8

10.1

40.8

40.7

0.45

3638

35493

(3005322) IgE [Units/volume] in Serum or Plasma

513

3486

1.50

15.68

1.4

1.3

u/ml

280.7

297.3

0.11

473

3250

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

6.29

15.54

1.1

mg/l

42.0

51.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

140

658

2.13

15.45

3.0

4.8

mmol/l

23.8

23.7

0.13

124

601

(3002179) Metamyelocytes/100 leukocytes in Blood

386

2480

1.58

15.22

3.3

4.3

0.4

0.5

0.30

473

(3022145) Colonoscopy Study observation

473

3186

1.51

15.07

1.3

1.4

—

(1616796) Gas panel - Central venous blood

139

659

2.11

15.01

3.2

3.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

231

1303

1.79

14.94

2.3

2.6

e6/l

0.2

0.17

225

1251

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

195

1044

1.88

14.93

11.2

12.7

mmol/l

23.7

24.0

0.60

182

1001

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

383

2469

1.57

14.88

2.9

2.5

—

(1002224) Polysomnography panel

288

1740

1.67

14.56

1.1

—

(3008898) HLA-B27 [Presence]

348

2208

1.60

14.47

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

319

4832

0.63

14.27

1.3

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

213

1193

1.80

14.12

10.9

12.2

93.5

94.8

1.65

213

1188

(3026493) Urate [Moles/volume] in Serum or Plasma

831

6282

1.37

14.03

2.2

2.4

umol/l

1783.1

2610.9

0.43

710

5745

(3028026) IgM [Mass/volume] in Serum or Plasma

370

2405

1.56

13.86

1.5

1.8

g/l

1.3

1.2

0.55

340

2249

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

207

1162

1.79

13.63

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

208

1172

1.78

13.52

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

714

5297

1.39

13.50

2.8

2.5

u/l

5281.9

6763.5

0.55

216

2102

(42529406) Shigella sp [Presence] in Stool by Culture

209

1180

1.78

13.50

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

245

1451

1.70

13.37

1.7

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

692

5118

1.39

13.32

4.0

4.5

mg/mmol

11.4

13.2

0.35

469

3699

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

414

2784

1.51

13.27

3.0

2.5

29.7

31.4

2.65

324

2159

(3020779) Urea [Moles/volume] in Serum or Plasma

367

2406

1.55

13.24

10.2

9.9

mmol/l

5.8

6.2

1.06

358

2330

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

237

2.77

13.19

1.8

2.3

nmol/l

127.4

142.1

0.53

201

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

156

811

1.93

13.10

1.2

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

200

1125

1.79

13.09

1.3

1.5

titre

74.2

76.9

0.06

121

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

292

1831

1.61

12.76

6.2

5.6

mmol/l

24.2

0.24

287

1779

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

179

985

1.82

12.61

1.2

2.1

e6/l

12.4

19.9

0.68

135

761

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

179

985

1.82

12.61

1.2

2.1

e6/l

247.8

4420.0

0.58

140

800

(46235355) HIV 1 and 2 tests - Meaningful Use set

2136

18510

1.24

12.24

2.5

2.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

452

3147

1.46

12.17

2.3

2.7

g/l

10.1

10.3

0.79

407

2912

(3012516) Albumin [Mass/volume] in Urine

663

4967

1.37

11.71

3.3

3.7

mg/l

384.8

431.6

0.09

451

3537

(3020961) Endomysium IgA Ab [Titer] in Serum

440

3073

1.45

11.65

1.2

titre

374.6

185.5

0.51

(3028626) Oxygen [Partial pressure] in Capillary blood

255

1583

1.62

11.63

6.8

6.3

kpa

9.5

9.7

0.87

240

1513

(3022313) Gas panel - Capillary blood

292

1875

1.57

11.56

6.4

5.7

—

(40767503) Oxygen content in Capillary blood by calculation

112

543

2.06

11.50

2.3

18.6

17.7

1.78

271

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

267

1683

1.60

11.44

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

221

3461

0.61

11.35

1.4

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

205

3248

0.61

11.05

1.7

1.8

—

(3017509) Phencyclidine [Presence] in Urine

120

3.31

10.95

1.4

2.1

—

(4010399)

296

1931

1.55

10.93

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

169

957

1.77

10.87

1.2

2.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

380

5265

0.69

10.83

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

383

2645

1.46

10.75

3.2

4.3

1.5

1.6

0.76

337

2412

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

189

1112

1.70

10.62

1.3

2.0

mg/l

458.1

411.9

0.44

183

1061

(3003338) MCHC [Mass/volume]

4108

38512

1.29

10.53

15.5

11.3

g/l

334.5

334.6

0.32

4088

38143

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

251

1591

1.59

10.52

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

453

3257

1.41

10.22

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

171

992

1.73

10.13

1.1

2.0

mmol/l

3.6

3.5

0.99

162

931

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

178

1045

1.71

10.10

5.0

4.8

0.7

0.58

169

1016

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

209

2.62

9.95

1.5

1.6

nmol/l

1.0

1.8

2.04

163

(3003327) Ova and parasites identified in Stool by Light microscopy

296

1972

1.51

9.94

1.8

1.7

—

(40761535) Cells panel - Urine sediment

297

1986

1.51

9.80

3.2

3.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

179

1063

1.69

9.75

10.9

12.8

—

(3021901) Oxygen saturation in Capillary blood

431

2.08

9.62

2.4

3.8

—

(3008295) Osmolality of Serum or Plasma

324

2.24

9.44

1.8

2.1

mosm/kgh2o

290.3

289.8

0.09

253

(3004119) Hemoglobin [Mass/volume] in Venous blood

210

1316

1.60

9.27

5.0

4.8

g/l

132.8

134.7

0.61

205

1288

(3035637) Corticotropin [Mass/volume] in Plasma

119

637

1.86

9.26

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

251

1646

1.53

9.09

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

144

828

1.74

8.85

1.2

1.3

u/ml

45.5

38.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

256

3681

0.67

8.84

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

507

1.95

8.82

1.2

2.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

258

3699

0.67

8.78

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

259

3705

0.67

8.71

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

189

1174

1.61

8.68

2.7

3.3

ng/l

79.8

100.6

0.53

153

1004

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

259

3701

0.67

8.66

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

396

2.06

8.61

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1667

14468

1.21

8.46

3.2

2.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

264

3742

0.68

8.46

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

162

975

1.66

8.44

2.2

2.1

—

(44813793)

463

1.96

8.29

1.1

1.0

—

(3023410) Appearance of Cerebral spinal fluid

100

533

1.87

7.94

1.3

2.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

151

909

1.66

7.89

1.2

1.3

u/ml

3.9

16.2

2.54

132

(3024928) Oxygen saturation in Venous blood

106

577

1.83

7.88

6.2

5.9

—

(3023520) Reticulocytes [#/volume] in Blood

261

1781

1.47

7.84

2.6

3.5

e9/l

67.0

70.1

0.63

173

1223

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

161

988

1.63

7.80

1.5

1.4

u/l

12.0

14.5

0.65

119

862

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

278

1925

1.45

7.75

1.6

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

337

2417

1.40

7.73

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

292

3990

0.71

7.63

1.4

1.5

—

(40768804) Tissue Pathology biopsy report

1446

12489

1.20

7.55

1.9

1.8

—

(3020891) Body temperature

127

744

1.70

7.37

4.2

5.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

147

896

1.64

7.34

1.2

1.3

u/ml

1.6

7.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

459

3486

1.33

7.34

2.5

2.3

ug/l

1.0

1.2

2.96

407

3219

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

175

1117

1.57

7.23

2.0

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

151

931

1.62

7.21

2.7

2.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

362

2.00

7.20

1.1

u/ml

121.5

20.5

0.41

257

(3011985) Renin [Units/volume] in Plasma

396

1.96

7.20

1.8

1.6

mu/l

48.2

75.8

1.60

355

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

186

1207

1.54

7.14

1.5

2.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

149

920

1.62

7.08

3.8

4.3

mmol/l

25.2

24.9

0.52

143

884

(3001186) Copper [Moles/volume] in Serum or Plasma

117

2.80

6.91

1.5

umol/l

17.7

16.7

0.34

108

(3008152) Bicarbonate [Moles/volume] in Arterial blood

166

1061

1.56

6.83

5.3

7.3

mmol/l

24.3

23.9

0.64

157

984

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

160

1015

1.57

6.81

2.0

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

1234

10611

1.20

6.62

2.3

2.2

—

(3019060) Gas panel - Arterial blood

161

1031

1.56

6.59

3.8

5.5

—

(3006653) Thiamine [Moles/volume] in Blood

144

2.55

6.50

1.6

1.3

nmol/l

132.4

136.9

0.23

144

(3021879) Hepatitis B virus core Ab [Presence] in Serum

670

5454

1.25

6.19

1.6

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

468

1.81

6.18

4.2

3.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

120

1871

0.62

6.13

1.1

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

196

1331

1.47

6.11

1.7

1.9

g/l

0.2

0.24

185

1270

(3006270) Folate [Moles/volume] in Blood

204

2.24

6.10

1.1

nmol/l

406.3

415.1

0.10

199

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

386

1.88

6.04

1.5

1.4

pmol/l

352.3

375.5

0.18

307

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

199

1359

1.46

6.03

1.7

1.9

g/l

1.2

0.28

189

1298

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

231

1625

1.42

5.98

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

225

2.16

5.98

1.3

2.1

nmol/l

0.2

0.70

172

(3026389) Candida sp identified in Specimen by Organism specific culture

555

1.72

5.93

1.2

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

288

2.00

5.78

1.7

1.3

ug/l

5.7

5.8

0.01

253

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.86

5.73

1.4

nmol/l

109.0

91.8

0.28

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

221

1555

1.42

5.73

1.5

1.4

u/ml

241.2

217.7

0.62

126

933

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

325

1.92

5.64

1.1

1.2

—

65.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

119

738

1.61

5.64

1.6

1.8

g/l

0.8

0.7

0.06

576

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

446

1.78

5.62

3.3

3.2

94.2

95.1

0.09

424

(3020630) Protein [Mass/volume] in Serum or Plasma

184

1256

1.46

5.62

1.4

2.2

g/l

67.5

67.7

0.20

169

1196

(3016244) Insulin [Units/volume] in Serum or Plasma

105

633

1.65

5.57

2.6

3.4

mu/l

24.1

27.4

0.54

595

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

235

1681

1.40

5.56

1.1

u/ml

3.4

4.3

0.27

260

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

272

2.01

5.56

1.1

—

(40761536) Microorganisms panel - Urine sediment

452

3567

1.28

5.45

3.5

3.1

—

(4062490)

482

1.73

5.36

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

108

663

1.62

5.35

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

108

664

1.62

5.32

1.2

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

498

1.72

5.32

3.2

4.0

mmol/l

3.7

3.8

0.80

465

(3004716) Salmonella sp identified in Stool by Organism specific culture

435

3434

1.27

5.24

1.3

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

219

2944

0.72

5.23

1.4

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

487

1.71

5.18

1.3

1.4

g/l

6.5

0.06

354

(3002256) Pathology report gross observation

455

3619

1.26

5.15

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

430

1.76

5.11

1.3

pmol/l

98.4

56.0

0.52

116

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1049

9076

1.18

5.08

1.6

1.5

—

(3005033) Fetal Nuchal fold Thickness US

220

2936

0.73

5.03

1.4

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

113

714

1.57

5.00

2.7

3.0

nmol/l

0.9

0.7

1.21

102

620

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

122

1808

0.66

4.99

1.2

1.3

ug/l

4.9

4.1

0.33

117

1715

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

4.15

4.99

1.0

ng/l

198.8

212.3

0.17

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

236

2.02

4.96

1.6

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

486

1.70

4.96

1.3

1.4

g/l

0.3

0.4

0.69

351

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

376

1.80

4.95

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

210

2.08

4.93

1.2

1.1

nmol/l

0.2

4.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

348

1.83

4.93

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

487

1.69

4.92

1.3

1.4

g/l

2.8

0.05

353

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

349

1.82

4.88

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

349

1.82

4.88

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

349

1.82

4.88

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

350

1.82

4.84

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

294

1.89

4.81

1.1

1.4

u/l

10.4

23.9

0.98

262

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

199

2.09

4.80

1.5

1.4

u/l

5.3

6.3

0.54

166

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

351

1.81

4.80

1.2

—

(3000492) Spirometry study

507

4117

1.24

4.79

1.4

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

230

3019

0.74

4.73

1.4

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

303

1.87

4.72

2.2

2.0

—

(3025941) Bacteria identified in Stool by Culture

343

2669

1.29

4.65

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

124

817

1.51

4.58

1.3

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

250

1868

1.34

4.56

1.1

u/ml

5.3

8.1

1.82

160

1174

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

358

1.77

4.52

1.1

mg/l

276.8

281.8

0.21

330

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

178

1262

1.41

4.50

1.6

u/ml

100.2

102.3

0.10

204

(3000034) Microalbumin [Mass/volume] in Urine

172

2.13

4.46

2.5

2.9

mg/l

49.5

62.1

0.21

127

(3025130) Human papilloma virus identified in Specimen

122

812

1.49

4.31

1.6

1.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

128

863

1.48

4.25

1.6

1.7

titre

2240.0

3185.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

237

1.92

4.22

1.0

1.1

u/ml

6.2

14.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

138

2.22

4.17

2.3

2.5

nmol/l

1.3

1.4

0.16

118

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

101

651

1.54

4.16

1.4

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

534

1.60

4.16

1.1

1.2

—

(3049233) Organic acids panel - Urine

3.57

4.11

1.1

1.3

—

(3045414) Leukocytes [Presence] in Urine

194

1420

1.36

4.08

1.7

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

355

1.73

4.08

1.1

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.56

4.02

1.1

u/ml

0.0

0.54

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

357

1.72

4.01

1.1

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1252

11155

1.14

4.00

2.8

2.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

182

1325

1.37

3.97

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

572

1.56

3.96

1.7

2.0

ug/l

1.8

1.7

0.01

517

(3023420) DNA double strand Ab [Units/volume] in Serum

457

1.63

3.93

1.7

iu/ml

27.3

30.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.47

3.93

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.47

3.93

1.9

2.4

umol/l

30.4

29.3

0.14

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

157

1120

1.40

3.88

1.9

2.2

iu/l

3.6

4.1

0.25

465

(3011897) Casein IgE Ab [Units/volume] in Serum

238

1.87

3.85

1.4

1.3

u/ml

0.3

11.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.74

3.75

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

234

1785

1.31

3.75

1.1

u/ml

1.5

1.4

0.06

139

964

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

922

8075

1.16

3.74

2.2

2.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

239

1835

1.30

3.66

1.1

u/ml

3.0

2.9

0.03

552

(3024522) Salmonella sp identified in Specimen by Organism specific culture

375

1.67

3.64

1.3

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

160

2.04

3.63

1.2

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1847

16949

1.12

3.59

3.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

378

1.65

3.54

1.1

1.7

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.39

3.54

2.7

1.5

nmol/l

23.1

17.6

0.17

(3036489) Thrombin time

219

1670

1.31

3.54

2.6

3.5

20.6

21.4

2.44

195

1430

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.83

3.53

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

386

1.64

3.53

1.3

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

184

1369

1.34

3.53

1.6

nmol/l

0.3

0.5

4.74

158

1157

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.37

3.45

4.0

2.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

381

1.64

3.45

1.4

1.3

titre

353.0

278.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

404

1.62

3.44

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.42

3.44

1.2

1.5

2.1

8.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

104

706

1.46

3.41

3.9

6.1

1.8

0.01

648

(3028717) Thiamine [Mass/volume] in Blood

3.51

3.40

1.1

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

376

1.64

3.36

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

376

1.64

3.36

1.3

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

243

1.79

3.33

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

526

1.53

3.30

1.1

g/l

1.4

0.43

480

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

183

1377

1.32

3.28

1.7

2.0

u/l

38.4

39.8

0.41

162

1305

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

380

1.62

3.24

1.3

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

194

1475

1.31

3.23

3.1

3.8

157.3

161.1

0.27

182

1412

(3047181) Lactate [Moles/volume] in Blood

102

699

1.45

3.21

3.9

5.9

mmol/l

1.1

1.2

0.08

600

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

451

1.56

3.20

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

374

1.62

3.19

1.3

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

112

786

1.42

3.11

1.1

1.2

iu/ml

21.1

1926.7

1.00

257

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

260

2065

1.26

3.08

1.2

1.1

u/ml

2.4

2.3

0.05

145

1038

(3010144) Erythrocytes [#/volume] in Synovial fluid

150

1.98

3.08

1.4

1.5

e6/l

13272.2

30364.0

0.48

103

(3014051) Protein [Presence] in Urine by Test strip

100

689

1.44

3.08

2.0

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

417

1.57

3.06

1.4

1.5

g/l

10.0

10.4

0.40

367

(3006184) Hemoglobin [Mass/volume] in Capillary blood

633

1.46

3.05

1.8

2.2

g/l

141.8

134.9

2.36

504

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

450

1.54

3.02

1.4

1.5

g/l

3.5

3.8

1.67

339

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

450

1.54

3.02

1.4

1.5

g/l

6.9

7.2

0.63

359

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

450

1.54

3.02

1.4

1.5

—

(3003181) Sodium [Moles/volume] in Urine

311

1.66

3.01

1.8

2.7

mmol/l

65.5

80.7

1.61

263

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

482

1.52

3.01

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

435

1.55

3.00

1.4

1.5

g/l

2.8

3.0

1.78

353

(3000330) Specific gravity of Urine by Test strip

151

1123

1.34

2.96

2.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

2.96

0.0

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

328

1.63

2.95

1.3

1.5

g/l

0.0

0.00

313

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

687

1.43

2.95

1.3

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

242

1924

1.25

2.87

2.4

2.3

ml/min/173m2

85.7

85.8

0.01

697

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

354

1.60

2.86

1.1

1.3

u/ml

0.0

0.6

2.51

103

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.04

2.84

1.3

1.5

nmol/l

342.8

535.8

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

294

1.65

2.83

1.1

1.2

u/ml

5.8

13.8

0.66

221

(4034850)

123

895

1.37

2.80

7.9

6.5

—

(4027681)

419

1.54

2.80

1.4

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

596

1.45

2.79

1.2

—

(3011648) Oxygen content in Venous blood

280

1.66

2.79

7.3

8.3

12.3

11.6

0.66

280

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

228

1.74

2.78

1.2

1.1

93.3

0.00

104

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

106

754

1.40

2.77

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

327

1.61

2.75

1.3

1.5

g/l

0.0

0.00

313

(3001556) Androgen free Index in Serum or Plasma

143

1.94

2.74

1.3

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

164

1.87

2.74

1.5

1.7

29.1

41.1

0.95

110

(3040151) Glucose [Moles/volume] in Capillary blood

343

1.59

2.73

1.4

5.9

mmol/l

7.0

6.5

0.43

279

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

194

1513

1.28

2.72

3.5

4.2

g/l

3.3

0.35

177

1449

(3032641) Amino acids panel - Urine

3.19

2.71

1.1

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.94

2.69

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

223

1.73

2.69

1.1

—

(3022621) pH of Urine by Test strip

253

2038

1.24

2.69

2.3

2.4

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.82

2.68

1.2

umol/24h

0.2

0.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

384

1.55

2.68

1.4

1.6

g/l

0.6

0.3

0.37

358

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.28

2.66

2.7

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

449

1.50

2.64

1.3

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

340

1.57

2.59

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

382

0.49

2.59

4.9

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

382

0.49

2.59

2.5

3.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.15

2.58

1.2

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

364

1.55

2.58

1.2

1.5

g/l

0.0

0.50

348

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

516

1.46

2.58

1.2

1.1

mg/l

39.6

36.1

0.28

425

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

967

0.68

2.57

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

316

2620

1.20

2.54

2.2

22.8

21.3

0.41

558

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.56

2.53

1.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

350

1.56

2.53

1.3

1.5

g/l

39.8

0.00

323

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

627

1.41

2.49

1.4

1.3

umol/l

6.2

6.1

0.04

578

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

512

1.45

2.49

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

414

0.52

2.47

1.3

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

237

1.67

2.46

1.2

1.1

94.7

92.9

0.23

107

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

498

1.45

2.44

1.1

mg/l

204.0

219.6

0.46

433

(3017732) Neutrophils [#/volume] in Blood

304

2533

1.20

2.34

2.1

2.0

e9/l

4.0

4.2

1.43

231

2192

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

159

1.80

2.34

1.3

1.5

pmol/l

12.7

13.9

0.79

134

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

196

1.72

2.32

1.1

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

200

1600

1.24

2.31

3.1

4.5

94.8

95.1

0.06

186

1495

(3051611) Lipemic interference index of Serum or Plasma

304

1.56

2.29

3.0

4.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.12

2.27

1.9

3.1

mg/l

21.8

24.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

161

1.78

2.25

1.1

1.2

—

(1761868) Lipid panel - Serum or Plasma

1371

14456

0.91

2.23

2.2

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

426

1.47

2.23

2.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

575

1.40

2.21

1.5

mmol/l

14.7

11.3

1.38

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

534

1.41

2.20

1.0

—

(3051651) Icteric interference index of Serum or Plasma

245

1.62

2.20

3.0

4.4

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

5.49

2.19

1.2

1.3

nmol/l

197.6

267.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

602

1.38

2.17

1.1

u/ml

0.5

3.7

2.32

258

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

237

1945

1.21

2.16

1.8

ug/l

0.4

0.5

3.61

133

772

(3011325) HIV 1+2 Ab [Presence] in Serum

2.75

2.14

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

456

0.58

2.13

1.4

1.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

334

1.51

2.12

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.10

2.11

2.6

2.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

180

1.70

2.09

1.6

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

144

1.79

2.06

1.0

1.1

u/ml

0.3

1.7

1.10

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

227

1.61

2.04

1.5

1.7

61.3

47.7

1.01

161

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

106

797

1.32

2.04

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

354

1.48

2.02

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

330

1.50

2.02

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

299

1.52

1.99

1.0

u/ml

2.5

9.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.37

1.97

1.4

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

700

1.33

1.94

4.0

6.2

0.9

0.14

643

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.98

1.93

2.4

2.5

ug/g

225.2

168.9

0.80

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.49

1.92

1.2

1.1

nmol/24h

56.4

103.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

279

1.53

1.89

5.7

8.0

mg/l

9.3

9.5

0.13

254

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

240

1.57

1.88

1.7

1.6

nmol/l

4.4

5.6

1.94

229

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

207

1705

1.21

1.86

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

318

2720

1.16

1.85

4.2

4.6

u/l

214.0

237.1

3.31

301

2602

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1062

0.75

1.84

1.5

1.6

mmol/l

7.8

7.4

0.76

645

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.06

1.80

1.1

1.5

ng/l

8.5

23.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

111

859

1.28

1.77

1.7

2.1

mg/l

9.1

9.7

0.56

102

820

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

457

1.39

1.75

1.7

1.6

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

198

1.60

1.74

1.3

1.2

g/l

0.3

0.56

158

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

302

1.47

1.72

1.3

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

733

1.30

1.70

1.6

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.88

1.69

3.4

2.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

239

1.53

1.69

1.9

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

132

1.72

1.66

1.0

1.1

u/ml

0.0

0.6

1.40

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

193

1.59

1.66

1.2

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

193

1.59

1.66

1.2

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

193

1.59

1.66

1.2

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

203

1691

1.19

1.65

1.6

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

125

1.74

1.65

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.93

1.63

10.2

8.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

549

1.34

1.62

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

250

1.50

1.61

1.4

2.2

mg/l

42.8

27.3

0.55

196

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.07

1.60

9.5

7.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

407

1.39

1.59

1.4

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

603

1.31

1.58

1.1

u/ml

1.0

9.1

1.58

230

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

919

9713

0.92

1.55

1.6

1.5

—

(3002619) Bacteria identified in Specimen by Culture

1.88

1.54

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

143

1.66

1.54

1.0

1.1

u/ml

0.2

4.7

0.97

(3017315) Amylase [Enzymatic activity/volume] in Urine

182

1.58

1.52

1.1

1.3

u/l

310.8

384.8

0.27

164

(3004616) Nuclear Ab [Presence] in Serum

352

1.41

1.52

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

436

1.36

1.52

1.5

1.8

e6/l

5689.4

11374.4

1.46

318

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

262

1.47

1.51

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.80

1.51

1.0

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.83

1.50

3.7

5.6

mmol/l

1.2

0.73

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.56

1.49

1.3

2.2

—

(3037121) Protein [Mass/volume] in Urine

147

1203

1.21

1.48

4.5

4.7

g/l

0.3

0.4

1.19

687

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

734

1.27

1.45

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

217

1.50

1.43

1.3

1.2

u/l

105.4

85.3

0.32

150

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

114

913

1.24

1.42

6.6

6.8

iu/ml

902.6

762.4

0.10

110

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

3.09

1.42

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

250

1.46

1.41

1.4

2.2

mg/l

39.6

33.7

0.31

196

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.69

1.41

1.3

pmol/l

19.5

14.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

166

1934

0.84

1.40

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

426

1.35

1.39

2.3

4.0

u/ml

24.1

111.5

2.45

133

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.85

1.39

6.3

5.9

—

(3016031) Almond IgE Ab [Units/volume] in Serum

102

1.74

1.39

1.1

1.0

u/ml

0.5

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

196

0.50

1.38

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

173

1449

1.18

1.37

1.1

u/ml

7.7

5.5

0.34

689

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.38

1.37

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

137

1124

1.21

1.36

2.8

4.1

ug/l

2.2

49.9

0.76

754

(3020393) Adenovirus Ag [Presence] in Stool

149

1.59

1.34

2.6

1.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.90

1.34

1.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

1.33

0.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

354

1.37

1.32

1.4

1.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

543

1.29

1.31

1.1

u/ml

0.2

1.7

1.22

103

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.81

1.30

7.1

5.9

—

(40768443) Skin Pathology biopsy report

145

1204

1.19

1.29

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

151

1.57

1.28

2.5

5.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

105

1.69

1.27

1.7

ug/min

26.0

45.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

315

1.38

1.26

1.0

1.1

u/l

0.9

1.0

0.35

130

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.71

1.25

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

160

1.54

1.25

3.3

2.4

mmol/l

1.4

1.9

0.35

124

(3024891) Influenza virus A+B Ag [Presence] in Specimen

176

1491

1.17

1.25

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

299

1.39

1.24

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

299

1.39

1.24

1.3

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

106

1.68

1.24

1.8

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

2.20

1.22

1.8

2.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

138

1147

1.19

1.22

1.1

u/ml

0.3

0.4

0.48

320

(3025315) Body weight

2.37

1.22

4.2

2.8

—

(3035880) pH of Pleural fluid

2.37

1.22

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

386

1.33

1.20

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

107

1.66

1.20

3.8

2.8

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.60

1.20

2.0

1.6

—

(40768446) Kidney Pathology biopsy report

203

1.46

1.17

1.9

2.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

179

1.49

1.17

1.1

u/ml

7.2

6.3

0.06

149

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

112

918

1.21

1.17

1.8

2.1

g/l

1.2

0.09

808

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

124

1.59

1.15

1.5

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.81

1.15

1.4

1.6

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

1.14

0.0

1.0

—

16.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

229

1.43

1.14

1.5

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

254

1.40

1.14

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

373

1.33

1.13

1.3

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

2.47

1.13

1.0

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.47

1.13

2.2

1.8

—

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

197

1.46

1.12

1.5

2.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.68

1.12

1.4

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

391

1.32

1.12

1.5

1.6

—

(3000012) Reticulocyte production index

102

1.65

1.11

1.1

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

110

1.62

1.10

2.0

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

126

1.57

1.09

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

393

1.31

1.09

1.8

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.66

1.09

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

376

1.32

1.08

2.2

3.0

1.7

1.1

0.54

300

(3043410) Blood group antigens tested for on Red Blood Cells

103

1.63

1.07

2.2

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

2.35

1.07

1.0

g/l

163.0

167.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.35

1.07

1.0

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

101

829

1.21

1.06

3.5

4.0

55.7

55.1

0.20

101

829

(3044242) Glucose [Moles/volume] in Arterial blood

1.71

1.04

1.4

2.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

431

1.29

1.04

1.9

2.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

475

1.27

1.03

1.6

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

169

1.46

1.01

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

227

1.39

1.01

1.3

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

186

1614

1.14

1.01

1.1

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

156

1337

1.16

1.00

1.1

u/ml

12.9

7.4

0.78

666

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

236

1.38

1.00

1.5

1.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

178

1.44

0.99

9.4

6.1

mg/l

77.6

76.1

0.04

144

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.98

0.98

1.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

497

1.25

0.97

4.9

8.6

u/ml

0.3

0.72

257

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.74

0.96

2.5

2.7

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.96

0.0

11.8

—

126.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.92

0.95

5.7

5.8

mmol/l

5.5

6.6

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

247

1.36

0.95

1.4

2.2

ng/l

166.7

122.3

1.67

218

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.78

0.94

1.2

1.5

pmol/l

472.0

315.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

123

1.53

0.94

2.0

1.5

—

(4024509)

231

0.64

0.94

1.1

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

294

3190

0.90

0.94

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

429

1.27

0.94

2.0

2.2

—

(3044941) Cell count panel - Synovial fluid

316

1.31

0.94

1.3

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.74

0.93

2.9

1.6

—

(3009677) Dengue virus Ab [Presence] in Serum

2.19

0.92

1.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.12

0.90

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

467

1.25

0.90

2.1

2.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

166

1.43

0.89

1.0

mg/g

4.6

5.6

1.06

161

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

183

1.40

0.88

1.2

1.1

u/ml

4.0

2.5

0.29

151

(3021788) Differential panel - Synovial fluid

372

1.28

0.88

1.4

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

126

1.49

0.86

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

373

1.27

0.86

1.6

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.98

0.86

1.2

1.6

umol/24h

277.3

265.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

705

0.81

0.85

2.5

2.6

mg/l

27.6

24.9

0.20

436

(3038177) Helicobacter pylori Ab [Presence] in Serum

814

1.18

0.85

1.2

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

815

1.18

0.84

3.4

3.7

e9/l

3.9

3.8

0.11

815

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

111

1.51

0.83

3.6

4.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

103

1.53

0.83

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

564

1.21

0.81

3.2

4.2

u/ml

6.6

7.3

0.08

491

(3024471) HLA-A [Type]

178

1.39

0.81

1.0

—

(3044927) Protein electrophoresis panel - Urine

1.57

0.80

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.57

0.80

1.1

2.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

104

1.52

0.80

1.6

—

6.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

162

1.40

0.79

1.7

2.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

140

1565

0.88

0.79

1.6

iu/ml

3.7

0.2

0.45

313

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.78

0.0

2.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.78

0.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

113

1.49

0.78

2.1

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

114

978

1.15

0.78

1.1

u/ml

3.3

2.9

0.19

487

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

105

1.51

0.77

1.1

u/ml

14.2

9.2

0.32

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

123

0.56

0.77

2.1

2.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

478

1.22

0.76

1.7

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

344

0.74

0.76

2.9

3.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

130

1.44

0.76

1.4

2.3

—

(3003694) ABO and Rh group [Type] in Blood

1473

14999

0.96

0.75

1.6

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4124

40313

1.05

0.75

4.4

4.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

462

1.22

0.74

1.8

2.8

74.5

72.1

0.74

451

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.67

0.72

2.3

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

106

0.56

0.72

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

560

0.81

0.72

1.0

1.1

—

(40768441) Liver Pathology biopsy report

269

1.29

0.71

1.7

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

710

0.83

0.71

1.2

1.4

nmol/l

17.8

32.3

4.39

651

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.59

0.71

1.1

—

(3014271) Vancomycin [Susceptibility]

1.73

0.70

2.6

1.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

100

1132

0.87

0.70

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

158

1.38

0.69

1.2

1.1

—

(4038314)

101

1.47

0.66

1.1

1.2

—

(3024932) HLA-DR beta [Type]

177

1.34

0.66

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

808

1.15

0.65

1.2

1.3

u/ml

2.2

5.0

1.73

302

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.51

0.65

1.2

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.51

0.65

1.2

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

118

1.42

0.65

1.1

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

118

1.42

0.65

1.1

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

118

1.42

0.65

1.1

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

118

1.42

0.65

1.1

1.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

265

1.27

0.64

2.8

1.6

mg/l

17.5

27.4

1.00

(3011412) CD3 cells [#/volume] in Blood

535

1.18

0.63

1.9

3.0

e9/l

1.6

1.3

0.78

319

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1498

14385

1.04

0.63

1.9

1.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

1.36

0.61

9.1

7.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.61

0.61

1.0

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

1.65

0.60

1.0

5.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.65

0.60

2.4

1.9

mmol/l

8.0

6.6

—

(3013762) Body weight Measured

0.00

0.60

0.0

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

339

1.22

0.60

1.8

1.4

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.60

0.0

1.1

—

37.5

—

(4306422)

769

1.14

0.59

1.1

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

457

1.19

0.59

1.8

2.8

9.6

11.3

0.98

325

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

684

0.85

0.59

1.6

2.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.58

0.0

1.1

—

71.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

790

1.14

0.57

1.3

u/ml

4.0

4.5

0.22

374

(3017704) Immunofixation for Urine

1.49

0.57

1.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

810

1.14

0.56

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.60

0.55

1.5

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.60

0.55

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

247

2617

0.93

0.54

2.3

2.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

211

1.26

0.52

1.8

2.7

60.0

53.8

0.84

133

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

121

1078

1.11

0.52

1.1

au/ml

23.3

9.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1082

0.89

0.51

1.2

—

(3006598) pH of Arterial cord blood

0.60

0.51

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

142

1.32

0.50

1.1

1.0

u/ml

0.0

0.1

0.86

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

166

0.71

0.50

1.1

3.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

166

0.71

0.50

1.1

3.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

734

1.13

0.50

6.2

5.3

u/ml

245.6

921.5

—

(4094501)

457

1.17

0.50

1.0

1.1

—

(3024263) Appearance of Synovial fluid

1.41

0.50

1.4

2.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

160

1.30

0.49

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

285

1.21

0.49

1.3

1.1

—

(3042733) HLA Ab [Presence] in Serum

178

1.28

0.49

5.7

4.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.54

0.48

4.7

4.5

—

(3023419) Bacteria identified in Sputum by Culture

198

0.75

0.48

1.3

4.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.45

0.48

1.5

1.7

nmol/l

4.1

429039.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

115

1250

0.91

0.47

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

324

3025

1.06

0.47

1.4

1.3

miu/ml

237.5

233.2

0.06

113

1498

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

118

1.34

0.47

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.41

0.46

1.6

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.43

0.45

3.0

2.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

102

1.36

0.44

2.7

3.4

—

(3004775) Volume in Urine collected for unspecified duration

137

1.30

0.44

1.6

2.3

899.5

636.2

1.10

102

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

462

0.85

0.42

2.5

2.6

ug/min

52.3

133.2

1.73

313

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.54

0.42

1.0

1.9

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.39

0.41

1.4

1.9

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.41

0.0

7.5

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.40

0.0

1.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

300

0.82

0.40

1.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.34

0.40

1.6

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

329

1.17

0.40

1.4

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.45

0.40

1.2

1.1

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

4.4

—

16.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.40

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.2

—

27.4

—

(4281824)

191

0.77

0.39

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.41

0.39

1.0

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1266

12766

0.97

0.39

1.9

1.8

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.37

0.38

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.37

0.38

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.37

0.38

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.37

0.38

1.1

—

(44790047)

451

1.14

0.38

1.6

1.7

—

(44790049)

451

1.14

0.38

1.6

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.37

0.37

1.0

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.37

0.37

1.2

1.3

—

4.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

461

1.14

0.37

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.35

0.37

1.3

2.4

—

(44790048)

452

1.14

0.37

1.6

1.7

—

(44806118)

452

1.14

0.37

1.6

1.7

—

(3020650) Glucose [Presence] in Urine

145

0.75

0.37

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

141

1.26

0.37

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

117

1250

0.92

0.36

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

1.27

0.36

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

296

1.17

0.36

1.1

1.3

—

(3045788) Cell count panel - Pleural fluid

0.64

0.35

1.2

1.6

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

205

1.20

0.35

1.9

2.1

au/ml

58.3

172.5

—

(3038026) Centromere Ab [Units/volume] in Serum

205

1.20

0.35

1.4

1.3

—

47.6

—

(3015183) Erythrocyte sedimentation rate

326

0.85

0.34

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.38

0.34

1.0

1.1

—

2.7

—

(44806071)

1.37

0.34

1.1

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

251

0.83

0.34

1.0

1.1

106.6

89.6

1.96

199

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.35

0.34

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

179

1.21

0.34

1.3

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

1.34

0.34

1.3

1.4

g/l

43.4

37.6

1.14

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

186

0.80

0.33

1.3

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

409

0.87

0.33

1.1

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.67

0.33

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

0.67

0.33

1.3

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.67

0.32

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

561

1.11

0.32

1.3

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.35

0.32

1.1

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.35

0.32

1.1

2.3

—

(40768795) Lymph node Pathology biopsy report

238

0.83

0.31

1.1

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

130

0.76

0.31

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

469

0.88

0.31

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

184

0.80

0.31

1.9

2.2

u/field

3.1

1.7

—

111

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.33

0.31

1.0

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

404

1.12

0.30

1.9

3.0

e6/l

947.4

864.4

0.23

123

(3034274) Bile acid [Moles/volume] in Serum --fasting

175

1636

1.06

0.29

2.9

2.6

umol/l

7.2

6.3

0.28

124

1245

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

128

0.77

0.29

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.29

0.27

1.5

1.7

u/l

8.7

12.3

2.32

(1617658) Protocol used for examination of sentinel lymph nodes

119

0.75

0.27

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

221

1.16

0.27

1.1

—

(3045142) Bone marrow Pathology biopsy report

233

0.85

0.26

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

203

1.17

0.26

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

148

1.20

0.26

1.1

1.8

—

(4133840)

126

0.78

0.26

1.0

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

334

1.12

0.26

2.0

2.9

26.2

27.4

0.36

328

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.25

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.20

0.25

1.2

1.4

—

(4268621)

562

1.09

0.25

2.2

2.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

439

1.10

0.24

1.2

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

458

1.10

0.24

2.0

3.0

e9/l

0.2

0.47

362

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.74

0.24

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.25

0.24

3.2

6.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

198

0.85

0.23

1.6

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.30

0.23

1.4

2.0

ng/l

70.3

100.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.30

0.23

3.0

2.4

pmol/l

63.4

48.8

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

160

1.17

0.22

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

160

1.17

0.22

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

160

1.17

0.22

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

910

1.06

0.22

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.23

0.22

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.27

0.22

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

322

0.89

0.22

1.0

1.1

miu/ml

1746.6

1475.7

0.55

322

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

170

1.16

0.21

1.1

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

320

1.11

0.21

1.9

3.3

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.21

0.0

3.7

—

139.4

—

(4212803)

0.00

0.21

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

122

0.81

0.21

1.0

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

143

1.17

0.20

1.7

1.8

mg/l

4.0

2.7

0.32

134

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.26

0.20

1.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.20

0.0

5.1

—

(40768793) Breast Pathology biopsy report

579

1.07

0.20

1.2

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

184

0.86

0.19

5.0

7.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

768

0.94

0.19

1.4

1.6

mmol/l

6.3

6.6

0.49

536

(3028433) Virus identified in Specimen by Culture

144

1.17

0.19

1.0

1.3

—

(4211845)

172

1.15

0.19

1.9

2.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

131

0.83

0.19

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

135

1.17

0.19

1.5

u/l

5.1

3.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

359

0.91

0.18

1.1

1.3

—

(3034426) Prothrombin time (PT)

182

1.14

0.18

1.2

1.3

—

(3017569) Oxygen content in Arterial blood

1.13

0.17

2.4

3.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.71

0.16

2.6

6.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

913

1.05

0.16

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

156

1.14

0.16

2.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.11

0.16

1.0

1.2

—

(3016750) Collection duration of Urine

119

1.16

0.15

1.5

2.4

min

527.2

518.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.75

0.15

1.0

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

462

1.07

0.15

2.0

3.0

e6/l

496.5

522.6

0.22

360

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

546

5301

1.02

0.15

1.9

2.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.10

0.15

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

525

0.94

0.14

1.4

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

282

1.09

0.13

1.6

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

426

1.07

0.13

1.3

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

446

1.06

0.13

1.0

1.1

iu/ml

6.7

6.3

0.04

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.17

0.12

1.5

ug/l

10.5

8.3

1.43

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

178

1.11

0.12

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

399

0.94

0.11

3.7

4.3

mg/l

8.8

8.6

0.07

326

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

237

1.08

0.11

2.1

2.6

45.1

43.5

0.15

(4146454)

133

1.11

0.10

3.7

2.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.14

0.10

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.07

0.09

1.6

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

365

1.06

0.09

2.8

3.5

au/ml

301.8

107.8

—

(4035726)

195

1887

1.02

0.09

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

1.12

0.09

1.3

1.2

—

(3019174) dRVVT (LA screen)

1.12

0.09

1.3

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

145

1464

0.98

0.08

1.8

1.9

—

(40758292) HTLV I+II Ab panel - Serum

1.13

0.08

1.0

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

132

0.90

0.08

1.1

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.81

0.08

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.80

0.08

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.78

0.08

1.0

1.1

—

(3004451) EKG impression Narrative

0.77

0.08

1.0

1.2

—

(3042631) Mycobacterium sp identified in Specimen

162

0.91

0.08

2.3

3.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

844

0.97

0.08

2.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

293

0.94

0.07

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.83

0.07

7.7

5.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

465

1.04

0.07

1.4

2.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.84

0.07

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

107

1.11

0.07

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.86

0.06

1.6

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

201

0.93

0.06

2.5

2.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

130

0.91

0.06

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

243

1.06

0.06

2.0

2.3

—

(3030313) Adrenal Ab [Titer] in Serum

1.11

0.06

1.4

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

129

0.92

0.05

1.1

1.3

—

(3037756) Immunofixation for Serum or Plasma

169

0.93

0.05

1.1

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

128

0.93

0.04

2.1

3.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

158

1.06

0.04

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

345

0.97

0.02

1.1

ratio

1.0

1.1

—

134

(3020491) Glucose [Moles/volume] in Blood

317

1.03

0.02

1.4

1.6

mmol/l

6.7

5.7

0.52

265

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

740

1.01

0.02

1.1

113.0

113.7

0.07

669

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

175

0.96

0.01

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

105

0.94

0.01

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

105

0.94

0.01

1.1

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

105

0.94

0.01

1.1

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

124

0.96

0.00

3.6

3.1

u/ml

17.7

42.7

1.15

124

(3041806) Other cells [#/volume] in Blood by Manual count

736

0.99

0.00

1.6

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

261

1.02

0.00

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

269

0.99

0.00

1.3

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

145

1.02

0.00

2.0

1.8

—

(21494434) Karyotype in Bone marrow

172

0.98

0.00

1.4

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

129

0.99

0.00

1.1

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

273

1.01

0.00

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

252

1.02

0.00

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

285

1.00

0.00

1.3

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

211

0.98

0.00

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

102

0.97

0.00

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

771

1.00

0.00

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

317

1.00

0.00

2.3

3.0

e6/l

312.8

251.6

0.40

196

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.93

0.00

6.7

5.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

77.8

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.96

0.00

1.3

3.4

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

2.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.3

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.5

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.94

0.00

1.0

1.2

mmol/l

5.7

6.0

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

6.6

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

9.5

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.96

0.00

1.5

1.6

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.1

—

(3018487) Sunflower Seed IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.01

0.00

2.1

1.6

mg/l

2.2

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.99

0.00

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.91

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_HYPERKIN – Hyperkinetic disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hyperkinetic disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Hyperkinetic disorders (KRA_PSY_HYPERKIN)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints